Family of patient who died during a clinical trial receive a six figure settlement

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e7793 (Published 15 November 2012)
Cite this as: BMJ 2012;345:e7793

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Clare Dyer
  1. 1BMJ

The family of a patient who died during a clinical trial at the Royal Marsden Hospital in London to test a five drug combination for treating testicular cancer has won a six figure sum in an out-of-court settlement.

Gareth Kingdon, 39, was the first patient to die from side effects during the multicentre TE23 trial, which was funded by the Medical Research Council to compare treatment of poor prognosis testicular cancer by five drugs instead of the standard three drug regime.

The family of another patient in the trial, 27-year-old Gary Foster, who was treated at University College London Hospital …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL